On behalf of the European Organisation for Research and Treatment of Cancer (EORTC), it is with great pleasure that we invite you to participate in a conference being held on the occasion of the 50th anniversary of the founding of the EORTC. The EORTC is a unique organization, a vibrant example of the fact that clinical and translational cancer research recognize no national boundaries. Established in 1962, the EORTC is both multinational and multidisciplinary, and the EORTC Network comprises over 300 hospitals and cancer centers in over 30 countries which include some 2,500 collaborators from all disciplines involved in cancer treatment and research. The 180 members of the EORTC Headquarters staff handle some 6,500 new patients enrolled each year in cancer clinical trials, approximately 30 protocols that are permanently open to patient entry, over 50,000 patients who are in follow-up, and a database of more than 180,000 patients. This conference offers a unique opportunity to gather those involved in EORTC activities which include the unique network of investigators but also national research organizations, health authorities, patient advocacy groups, European Commission, cancer leagues, and the pharmaceutical industry.

This course is designed as an introduction to the statistical principles, which form the basis for the design and analysis of cancer clinical trials. It will concentrate on the philosophy and understanding of the statistical principles that are used on a day-to-day basis in conducting clinical trials and will not simply present statistical formulae in a cookbook fashion. This course is aimed at non statisticians (medical doctors, data managers, etc.) who are already working in the field of clinical trials and who have completed an introductory course in statistics, or at statisticians with little or no experience in clinical trials.

This course is designed at an advanced level for medical doctors, specialists in oncology, and cancer clinical research professionals. The course will focus on the new aspects and methodological challenges of modern cancer clinical trials. The course will address new clinical trials features aimed at understanding the biology of the disease and document molecular determinants whether host or disease related which may be prognostic or /predictive of patient outcome. As innovative approaches will be discussed, attendees are expected to already have a good understanding of the basis of clinical trial methodology.

Education Office programs

EORTC homepage

FOR FURTHER INFORMATION PLEASE CONTACT
Ms. Danielle Zimmermann
EORTC Education Office
Avenue Emmanuel Mounier 83, bte 11
B - 1200 Brussels, Belgium
Phone: +32-2-774 16 02 / Fax: +32-2-772 62 33
E-mail: danielle.zimmermann@eortc.be